Jiaojiao Pang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

High Resolution Mass Spectrometry

Subarachnoid Hemorrhage

Coronary Artery Bypass Grafting

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jiali Lv, Chang Pan, Yuping Cai, Xinyue Han, Cheng Wang, Jingjing Ma, Jiaojiao Pang, Tonghui Xu, Shuo Wu, Tianzhang Kou, Fandong Ren, Zheng-Jiang Zhu, Tao Zhang, Jiali Wang, Yu-Guo Chen
Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease. Nature communications 15 (1) (2024)
Jiali Lv, Chang Pan, Yuping Cai, Xinyue Han, Cheng Wang, Jingjing Ma, Jiaojiao Pang, Tonghui Xu, Shuo Wu, Tianzhang Kou, Fandong Ren, Zheng-Jiang Zhu, Tao Zhang, Jiali Wang, Yu-Guo Chen
Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease. Nature communications 15 (1) (2024)
Jiali Lv, Chang Pan, Yuping Cai, Xinyue Han, Cheng Wang, Jingjing Ma, Jiaojiao Pang, Tonghui Xu, Shuo Wu, Tianzhang Kou, Fandong Ren, Zheng-Jiang Zhu, Tao Zhang, Jiali Wang, Yu-Guo Chen
Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease. Nature communications 15 (1) (2024)
Jiaojiao Pang, Tonghui Xu, Gianmarco Aondio, Yu Li, Alberto Fumagalli, Ming Lu, Giuseppe Valmadre, Jie Wei, Yuan Bian, Margherita Canesi, Giovanni Damiani, Yuan Zhang, Dexin Yu, Jun Chen, Xiang Ji, Wenhai Sui, Bailu Wang, Shuo Wu, Attila Kovacs, Miriam Revera, Hao Wang, Xu Jing, Ying Zhang, Yu-Guo Chen, Yihai Cao
Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nature communications 12 (1) (2021)